CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
Jaehyun Lee, Yong Jae Shin, Kyoungmin Lee, Hee Jin Cho, Jason K. Sa, Sang-Yun Lee, Seok-Hyung Kim, Jeongwu Lee, Yeup Yoon, Do-Hyun Nam
Cancer Research and Treatment. 2018;50(3):1009-1022.   Published online 2017 November 10    DOI: https://doi.org/10.4143/crt.2017.315

Excel Download

Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
Cancer Research and Treatment. 2018;50(3):1009-1022   Crossref logo
Link1 Link2 Link3

EXTH-73. A NOVEL ANTI-GALECTIN-3 MONOCLONAL ANTIBODY THERAPEUTIC DIMINISHES MIGRATION AND SLOWS TUMOR GROWTH TO PROLONG SURVIVAL IN GLIOBLASTOMA
Neuro-Oncology. 2022;24(Supplement_7):vii226-vii226   Crossref logo
Link1 Link2

A novel anti-DR5 chimeric antibody and epirubicin synergistically suppress tumor growth
IUBMB Life. 2012;64(9):757-765   Crossref logo
Link1 Link2

EXTH-67. THERAPEUTIC EFFICACY OF GC1118, A NOVEL ANTI-EGFR ANTIBODY, AGAINST GLIOBLASTOMA WITH HIGH EGFR AMPLIFICATION IN PATIENT-DERIVED XENOGRAFTS
Neuro-Oncology. 2021;23(Supplement_6):vi178-vi178   Crossref logo
Link1 Link2

25. Genetically Modified T Cells Directed to Glioblastoma Suppress Tumor Growth in a Rodent Glioma Model
Molecular Therapy. 2011;19:S10   Crossref logo
Link1 Link2

Targeting ERBB2 overcomes resistance to the anti-EGFR therapeutic antibody cetuximab
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies. 2023;75-81   Crossref logo
Link1 Link2

Interferon as an Antiviral and Anti-tumor Therapeutic Agent
Ophthalmology. 1980;87(12):1236-1238   Crossref logo
Link1 Link2

532. Neuropilin-1 Expressing Mononuclear Cells (NEMs), a Novel Population of Bone Marrow Cells Recruited by AAV2-Sema3A, Contributes to Vessel Normalization and Inhibits Tumor Growth
Molecular Therapy. 2011;19:S204   Crossref logo
Link1 Link2

CT16: A dual antibody targeting both EGFR and Notch suppresses EGFR blockage and radiation resistance by decreasing tumor-initiating cell frequency
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies. 2023;83-89   Crossref logo
Link1 Link2

EXTH-19. EVALUATING THE ANTI-TUMOR EFFECT OF A NOVEL THERAPEUTIC AGENT, MAGMAS INHIBITOR, IN MALIGNANT GLIOMA
Neuro-Oncology. 2020;22(Supplement_2):ii90-ii91   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.